News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Herde Kevin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Herde Kevin (CFO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 72,507 shares
@ $0
Granted 143,000 options to buy
@ $15.52, valued at
$2.2M
|
|
| 11/09/2022 |
4
| Herde Kevin (CFO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 478 shares
@ $14.11, valued at
$6.7k
|
|
| 06/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2022 |
4
| Herde Kevin (CFO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 497 shares
@ $22.95, valued at
$11.4k
Granted 392 shares
@ $22.95, valued at
$9k
Granted 19,500 shares
@ $0
Granted 36,200 options to buy
@ $26.32, valued at
$952.8k
|
|
| 11/23/2020 |
4
| Herde Kevin (CFO) has filed a Form 4 on MARAVAI LIFESCIENCES HOLDINGS, INC.|
Txns:
| Granted 60,000 options to buy
@ $27, valued at
$1.6M
|
|
| 11/19/2020 |
3
| Herde Kevin (CFO) has filed a Form 3 on MARAVAI LIFESCIENCES HOLDINGS, INC. |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/16/2016 |
4
| Herde Kevin (Executive VP and CFO) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 50,000 options
@ $6.52, valued at
$326k
|
|
| 04/08/2016 |
3
| Herde Kevin (Executive VP and CFO) has filed a Form 3 on Sorrento Therapeutics, Inc. |
|
|